Yayınlar & Eserler

Yayın Ağı
Makaleler 175
Tümü (175)
SCI-E, SSCI, AHCI (147)
SCI-E, SSCI, AHCI, ESCI (166)
ESCI (9)
Scopus (159)
TRDizin (8)
Diğer Yayınlar (4)

1. Global Disparities and Trends in Radiotherapy for Early-Stage Glottic Cancer

Özyar E.
CURRENT ONCOLOGY , cilt.33, sa.5, ss.1-11, 2026 (SCI-Expanded, Scopus)

2. Multi-institutional deep learning for GTV segmentation and survival prediction in nasopharyngeal carcinoma

Yuce M., ERDOĞAN S. B., AKIN A., ÖZYAR E., Gungor G., Guvendiren B., et al.
BMC medical imaging , cilt.26, sa.1, 2026 (SCI-Expanded, Scopus)

3. Outcomes and PSA kinetics after Magnetic Resonance Image-Guided Stereotactic Body Radiotherapy (MRgSBRT) for prostate cancer

Atahan C., Ugurluer G., GUNGOR G., Dincer N., Celebi E., Gul A., et al.
Strahlentherapie und Onkologie , 2026 (SCI-Expanded, Scopus)

4. Initial experience with MR-guided adaptive spinal stereotactic radiotherapy: a new indication for the MR-linac

Dincer N., Zoto Mustafayev T., Atahan C., GUNGOR G., UĞURLUER G., ABACIOGLU M. U., et al.
Strahlentherapie und Onkologie , cilt.201, sa.12, ss.1289-1295, 2025 (SCI-Expanded, Scopus)

5. Definitive radiotherapy/chemoradiotherapy outcomes and toxicity profile in geriatric patients with cervical cancer: Turkish Society for Radiation Oncology Geriatric Oncology Group study (TROD 013-002)

ALSAN ÇETİN İ., Halis H., GÜLTEKİN M., Alanyali S., ERGEN Ş. A., İBİŞ K., et al.
EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY , cilt.46, sa.11, ss.49-59, 2025 (SCI-Expanded) Sürdürülebilir Kalkınma

6. A multicenter retrospective analysis of recurrent/metastatic nasopharyngeal cancer from non-endemic areas: Results in the pre-immunotherapy era

Alberti A., Gurizzan C., Resteghini C., Trama A., Bernasconi A., Grisanti S., et al.
European Journal of Cancer , cilt.229, 2025 (SCI-Expanded, Scopus)

7. International Consensus Guideline on Delineation of the Clinical Target Volumes at Different Dose Levels for Nasopharyngeal Carcinoma (2024 Version)

Lin S., Guo Q., Liu Q., Ng W., Ahn Y. C., AlHussain H., et al.
International Journal of Radiation Oncology Biology Physics , cilt.123, sa.2, ss.415-431, 2025 (SCI-Expanded, Scopus)

8. MR-guided online adaptive stereotactic body radiotherapy (MRgSBRT) of primary lung tumors and lung oligometastases

Ugurluer G., Dincer N., Mustafayev T. Z., Gungor G., Abacioglu M. U., Sengoz M., et al.
STRAHLENTHERAPIE UND ONKOLOGIE , cilt.201, sa.6, ss.637-644, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

9. Clinical Outcomes of Patients with Multiple Liver Metastases Treated with MR-Guided Stereotactic Radiotherapy

Atahan C., Dincer N., UĞURLUER G., ÖZYAR E., Atalar B.
RADIOTHERAPY AND ONCOLOGY , cilt.206, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

10. Stereotactic Radiotherapy in Brain Metastases: SRS/FSRT Paradox and Preferences of Radiation Oncologists in Turkey (TROD 10-010 Study)

Yildirim B. A., Esen C. S. B., YÜCE SARI S., ÖZYAR E., Guney Y.
RADIOTHERAPY AND ONCOLOGY , cilt.206, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

11. The role of radiotherapy in intracranial hemangiopericytoma/solitary fibrous tumors

Kaydihan N., Yazici G., ERPOLAT Ö. P., Kamer S., ERDEMCİ B., CANYILMAZ E., et al.
STRAHLENTHERAPIE UND ONKOLOGIE , cilt.201, sa.4, ss.431-437, 2025 (SCI-Expanded, Scopus)

12. Lorlatinib-Induced Blindness: A Rare Entity

Dincer N., Can O., Demir G., ÖZYAR E.
Practical Radiation Oncology , cilt.15, sa.2, ss.120-123, 2025 (SCI-Expanded, Scopus)

13. Clinical and radiological effects of Bevacizumab for the treatment of radionecrosis after stereotactic brain radiotherapy

Mustafayev T. Z., Turna M., Bolukbasi Y., Tezcanli E. K., Guney Y., DİNÇBAŞ H. F., et al.
BMC CANCER , cilt.24, sa.1, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

14. International Recommendations on Postoperative Management for Potentially Resectable Locally Recurrent Nasopharyngeal Carcinoma

Li J., Blanchard P., Wong C. H. L., Ahn Y. C., Bonomo P., Bresson D., et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS , cilt.120, sa.5, ss.1294-1306, 2024 (SCI-Expanded, Scopus)

15. Nuclear protein in testis (NUT) midline carcinoma of the larynx: A rare case report of a paediatric patient and literature review

UĞURLUER G., Dincer N., ERŞEN DANYELİ A., Celik L., Guner A. L., Corapcioglu F., et al.
CANCER RADIOTHERAPIE , cilt.28, sa.4, ss.385-389, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

16. Myonecrosis as a rare side effect of stereotactic body radiotherapy for bone metastases: Report of two cases and a comprehensive literature review

Atahan C., UĞURLUER G., Kumbasar B., ÖZYAR E., ATALAR B.
CANCER RADIOTHERAPIE , cilt.28, sa.3, ss.275-279, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

17. Factors influencing local control after MR-guided stereotactic body radiotherapy (MRgSBRT) for adrenal metastases

Ugurluer G., Schneiders F. L., Corradini S., Boldrini L., Kotecha R., Kelly P., et al.
CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY , cilt.46, 2024 (SCI-Expanded)

18. Awareness Level of Cervical Cancer Patients Referred to Radiation Oncology Outpatient Clinics-A Multicenter Study

Altinok P., Ergen S. A., Guzeloz Capar Z., CANYILMAZ E., Akguen Z., Serin M., et al.
JOURNAL OF LOWER GENITAL TRACT DISEASE , cilt.28, sa.2, ss.143-148, 2024 (SCI-Expanded, Scopus)

19. Online Adaptive Magnetic Resonance-guided Radiation Therapy for Gynaecological Cancers: Preliminary Results of Feasibility and Outcome

Uğurluer G., Mustafayev T. Z., Gungor G., Abacıoglu M. U., Atalar B., Özyar E.
CLINICAL ONCOLOGY , cilt.36, sa.1, ss.12-20, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

20. Dosimetric comparison of stereotactic MR-guided radiation therapy (SMART) and HDR brachytherapy boost in cervical cancer

Dincer N., Ugurluer G., Mustafayev T. Z., Serkizyan A., Aydin G., Güngör G., et al.
BRACHYTHERAPY , cilt.23, sa.1, ss.18-24, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

21. COST EFFECTIVENESS AND PUBLIC HEALTH IMPACT OF IMPLEMENTING GENDER-NEUTRAL VACCINATION WITH THE 9-VALENT HUMAN PAPILLOMAVIRUS VACCINE IN TURKIYE

Ersoy A. B., Koc E., Pavelyev A., Daniels V., Ugrekhelidze D., Malhan S., et al.
VALUE IN HEALTH , cilt.26, sa.12, 2023 (SCI-Expanded, SSCI, Scopus)

22. A Rare Case of BRAF-mutated Metastatic Pleomorphic Xanthoastrocytoma Patient who Developed Radiodermatitis After Receiving Anti-BRAF Treatment

Atahan C., Arslantas E., ERŞEN DANYELİ A., Celik L., Bozkurt G., UĞURLUER G., et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY , cilt.45, sa.8, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

23. DEFINITIVE RADIOTHERAPY/CHEMORADIOTHERAPY RESULTS IN GERIATRIC PATIENTS WITH CERVICAL CANCER

ALSAN ÇETİN İ., Halis H., GÜLTEKİN M., Alanyali S., ERGEN Ş. A., İBİŞ K., et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER , cilt.33, 2023 (SCI-Expanded, Scopus)

24. The effect of P53 expression and smoking/alcohol in P16 (+) and P16(-) oropharyngeal carcinoma and risk classification: the Turkish Society of Radiation Oncology Head & Neck Study Group 01-002

ÖZKAYA AKAGÜNDÜZ Ö., Etit D., YAZICI G., Veral A., ÇETİNAYAK H. O., Sarioglu S., et al.
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY , cilt.136, sa.1, ss.80-90, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

25. A multicenter retrospective analysis of patients with nasopharyngeal carcinoma treated in IMRT era from a nonendemic population: Turkish Society for Radiation Oncology Head and Neck Cancer Group Study (TROD 01-001)

Yildirim H. C., Kupik G. E., Mustafayev T. Z., Berber T., Yavuz B., Cetinayak O., et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK , cilt.45, sa.5, ss.1194-1205, 2023 (SCI-Expanded, Scopus)

26. Neoadjuvant mFOLFIRINOX vs mFOLFIRINOX Plus Radiotherapy in Patients With Borderline Resectable Pancreatic Cancer-The A021501 Trial

Dincer N., UĞURLUER G., ÖZYAR E.
JAMA ONCOLOGY , cilt.9, sa.2, ss.276-277, 2023 (SCI-Expanded, Scopus)

27. A multi-centric evaluation of self-learning GAN based pseudo-CT generation software for low field pelvic magnetic resonance imaging

Prunaretty J., Gungor G., Gevaert T., Azria D., Valdenaire S., Balermpas P., et al.
FRONTIERS IN ONCOLOGY , cilt.13, 2023 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma

28. Multi-institutional analysis of cervical esophageal carcinoma patients treated with definitive chemoradiotherapy: TROD 01-005 study

Guler O. C., Oymak E., YAZICI G., ÖZKAYA AKAGÜNDÜZ Ö., ÇETİNAYAK H. O., ERPOLAT Ö. P., et al.
ONCOLOGY RESEARCH , cilt.31, sa.3, ss.299-306, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

29. Current Status of Stereotactic Radiotherapy in Turkiye: Turkish Society for Radiation Oncology Stereotactic Radiotherapy Study Group 10-006 Survey

DURU BİRGİ S., Turna M., Caglar H. B., Yildirim B. A., YÜCE SARI S., AKYÜREK S., et al.
TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY , cilt.38, sa.4, ss.407-416, 2023 (ESCI, Scopus, TRDizin) Sürdürülebilir Kalkınma

30. Radiation therapy using MRI-Linac - the right way to start: a guide for physicians and physicists

ÖZYAR E., Ben-David M. A., Lagerwaard F.
FRONTIERS IN ONCOLOGY , cilt.13, 2023 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma

31. A National Survey on the Awareness of Artificial Intelligence Technologies Among Radiation Oncologists- Turkish Society of Radiation Oncology Artificial Intelligence and Information Technology Group Study

Kirakli E. K. O. R. K. M. A. Z., Gursel S. B., Erkal E. Y. I. R. M. I. B. E. S. O. G. L. U., ETİZ D., ÖZYAR E.
TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY , cilt.38, ss.1-8, 2023 (ESCI, Scopus)

32. Multi-Institutional Outcomes of Stereotactic Magnetic Resonance Image Guided Adaptive Radiation Therapy With a Median Biologically Effective Dose of 100 Gy(10) for Non-bone Oligometastases

Kutuk T., Herrera R., Mustafayev T. Z., Gungor G., Ugurluer G., Atalar B., et al.
ADVANCES IN RADIATION ONCOLOGY , cilt.7, sa.6, 2022 (ESCI, Scopus)

33. ASO Visual Abstract: Intervention for Hepatic and Pulmonary METastases in Breast Cancer Patients-Prospective, Multi-Institutional Registry Study: IMET; Protocol MF 14-02

Soran A., Ozbas S., ÖZÇINAR B., Isik A., Dogan L., ŞENOL K., et al.
ANNALS OF SURGICAL ONCOLOGY , cilt.29, sa.10, ss.6337-6338, 2022 (SCI-Expanded, Scopus)

34. Intervention for Hepatic and Pulmonary Metastases in Breast Cancer Patients: Prospective, Multi-institutional Registry Study-IMET, Protocol MF 14-02

Soran A., Ozbas S., ÖZÇINAR B., Isik A., Dogan L., ŞENOL K., et al.
ANNALS OF SURGICAL ONCOLOGY , cilt.29, sa.10, ss.6327-6336, 2022 (SCI-Expanded, Scopus)

35. Magnetic Resonance Imaging-Guided Radiation Therapy for Early-Stage Gastric Mucosa-Associated Lymphoid Tissue Lymphoma

Dincer N., Ugurluer G., Gungor G., Zoto Mustafayev T., Atalar B., Ozyar E.
CUREUS JOURNAL OF MEDICAL SCIENCE , sa.9, 2022 (ESCI)

36. Outcomes of carotid sparing intensity-modulated radiotherapy for early stage glottic cancer in 201 patients: Multicenter study of Turkish Radiation Oncology Society/TROD-01-007

Bicakci B. C., Mustafayev T. Z., ÇETİNAYAK H. O., Igdem S., Birgi S. D., Meydan D., et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK , cilt.44, sa.8, ss.1825-1832, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

37. Clinical evaluation of self-learning GAN based pseudo-CT generation software for low field pelvic MR

Fenoglietto P., Gevaert T., Boussaer M., Delasalles E., Ioannidou D., Shreshtha K., et al.
RADIOTHERAPY AND ONCOLOGY , 2022 (SCI-Expanded, Scopus)

38. AI-based OAR delineation in brain T1w-MRI: Overcoming Inter- and Intra-observer variability

GUNGOR G., Klausner G., Gur G., Serbez I., TEMUR B., Caffaro A., et al.
RADIOTHERAPY AND ONCOLOGY , cilt.170, 2022 (SCI-Expanded, Scopus)

39. AI surpassing human expert: a multi-centric evaluation for organ at risk delineation

Azria D., Boldrini L., De Ridder M., Fenoglietto P., Gambacorta M. A., Gevaert T., et al.
RADIOTHERAPY AND ONCOLOGY , 2022 (SCI-Expanded, Scopus)

40. Psychosocial Impact of the War in Ukraine on Pediatric Cancer Patients and Their Families Receiving Oncological Care Outside Their Country at the Onset of Hostilities.

Uğurluer G., Özyar E., Corapcioglu F., Miller R. C.
Advances in radiation oncology , cilt.7, sa.4, ss.100957, 2022 (Scopus) Sürdürülebilir Kalkınma

41. Magnetic Resonance Imaging-Guided Online Adaptive Lattice Stereotactic Body Radiotherapy in Voluminous Liver Metastasis: Two Case Reports

Dincer N., UĞURLUER G., Korkmaz L., Serkizyan A., ATALAR B., Gungor G., et al.
CUREUS JOURNAL OF MEDICAL SCIENCE , cilt.14, sa.4, 2022 (ESCI)

42. Intervention to hepatic and pulmonary METastases in breast cancer patients: Prospective, multi-institutional registry study-IMET; Protocol MF 14-02

Soran A., Ozbas S., ÖZÇINAR B., IŞIK A., Dogan L., ŞENOL K., et al.
ANNALS OF SURGICAL ONCOLOGY , cilt.29, sa.SUPPL 1, ss.30-31, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

43. Magnetic Resonance Image-Guided Hypofractionated Ablative Radiation Therapy for Hepatocellular Carcinoma With Tumor Thrombus Extending to the Right Atrium

Dincer N., UĞURLUER G., Mustafayev T. Z., Gungor G., ATALAR B., GÜVEN K., et al.
CUREUS JOURNAL OF MEDICAL SCIENCE , cilt.14, sa.4, 2022 (ESCI) Creative Commons License

44. Nasopharyngeal cancer in non-endemic areas: Impact of treatment intensity within a large retrospective multicentre cohort

Bossi P., Trama A., Bernasconi A., Grisanti S., Mohamad I., Galiana I. L., et al.
European Journal of Cancer , cilt.159, ss.194-204, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

45. Multi-Institutional Outcomes of Stereotactic Magnetic Resonance Image-Guided Adaptive Radiation Therapy (SMART) With Median Biologically Effective Dose of 100 Gy10 for Oligometastases

Chuong M. D., Herrera R., Mustafayev T. Z., GUNGOR G., Ugurluer G., Atalar B., et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS , cilt.111, sa.3, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

46. Risk of symptomatic radiation necrosis in patients treated with stereotactic radiosurgery for brain metastases.

Sayan M., Şahin B., Mustafayev T., Kefelioğlu E., Vergalasova I., Gupta A., et al.
Neurocirugia (Asturias, Spain) , cilt.32, ss.261-267, 2021 (SCI-Expanded, Scopus)

47. Human-Level Precision Upper Abdominal OAR Contouring With Anatomically Preserving Deep Learning During Magnetic Resonance Imaging Guided Adaptive Radiotherapy (MRgRT)

GUNGOR G., Michalet M., Lombard A., Roque T., ATALAR B., TEMUR B., et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS , cilt.111, sa.3, 2021 (SCI-Expanded, Scopus)

48. Long-Term Multi-Institutional Outcomes of 5-Fraction Ablative Stereotactic MR-Guided Adaptive Radiation Therapy (SMART) for Inoperable Pancreas Cancer With Median Prescribed Biologically Effective Dose of 100 Gy(10)

Chuong M. D., Kirsch C., Herrera R., Rubens M., GUNGOR G., Schaff E. M., et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS , cilt.111, sa.3, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

49. Dosimetric and Clinical Evaluation of Stereotactic MR-Guided Online Adaptive Radiation Therapy (SMART) for Treatment of Adrenal Metastases

UĞURLUER G., Serkizyan A., Mustafayev T. Z., ATALAR B., ABACIOGLU M. U., GUNGOR G., et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS , cilt.111, sa.3, 2021 (SCI-Expanded, Scopus)

50. Magnetic resonance image-guided hypofractionated ablative radiation therapy for extrahepatic cholangiocarcinoma: Plan adaptation in changing anatomy

Egriboyun S., UĞURLUER G., GUNGOR G., Zoto Mustafayev T., Cicek B., Demir G., et al.
Medical Dosimetry , cilt.46, ss.435-439, 2021 (SCI-Expanded, Scopus)

51. A pediatric cerebral tumor with MN1 alteration and pathological features mimicking carcinoma metastasis: may the terminology "high grade neuroepithelial tumor with MN1 alteration" still be relevant?

Sari R., Altinoz M. A., ÖZYAR E., Danyeli A., Elmaci I.
Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery , cilt.37, sa.10, ss.2967-2974, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

52. Long-term multi-institutional outcomes of 5-fraction ablative stereotactic MR-guided adaptive radiation therapy (SMART) for inoperable pancreas cancer with median prescribed biologically effective dose of 100 Gy10

Chuong M., Kirsch C., Herrera R., Rubens M., Gungor G., Schaff E., et al.
International Journal Of Radiation Oncology Biology Physics , cilt.111, sa.3, ss.96, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

53. Stereotactic MR-guided online adaptive radiation therapy for management of pancreatic malignancies

Mustafayev T. Z., UĞURLUER G., GUNGOR G., ATALAR B., Serkizyan A., ABACIOGLU M. U., et al.
RADIOTHERAPY AND ONCOLOGY , 2021 (SCI-Expanded, Scopus)

54. Clinical adoption patterns of 0.35 Tesla MR-guided radiation therapy in Europe and Asia

Clark M. A., Slotman B., ÖZYAR E., Kim M., Itami J., Tallet A., et al.
RADIOTHERAPY AND ONCOLOGY , cilt.161, 2021 (SCI-Expanded, Scopus)

55. The potential role of MR-guided adaptive radiotherapy in pediatric oncology: Results from a SIOPE-COG survey

Seravalli E., Kroon P. S., Buatti J. M., Hall M. D., Mandeville H. C., Marcus K. J., et al.
CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY , cilt.29, ss.71-78, 2021 (Hakemli Dergi)

56. International Recommendations on Reirradiation by Intensity Modulated Radiation Therapy for Locally Recurrent Nasopharyngeal Carcinoma

Ng W. T., Soong Y. L., Ahn Y. C., AlHussain H., Choi H. C. W., Corry J., et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS , cilt.110, sa.3, ss.682-695, 2021 (SCI-Expanded, Scopus) Creative Commons License

57. Magnetic resonance image-guided stereotactic body radiation therapy for liver rhabdoid tumor in infancy: A case report

Egriboyun S., UĞURLUER G., Corapcioglu F. V., Celik L., GUNGOR G., ATALAR B., et al.
Journal of Medical Imaging and Radiation Sciences , cilt.52, ss.305-311, 2021 (Hakemli Dergi)

58. Stereotactic MR-guided online adaptive radiation therapy (SMART) for the treatment of liver metastases in oligometastatic patients: initial clinical experience

UĞURLUER G., Mustafayev T. Z., GUNGOR G., ATALAR B., ABACIOGLU M. U., ŞENGÖZ K. M., et al.
RADIATION ONCOLOGY JOURNAL , cilt.39, sa.1, ss.33-40, 2021 (Hakemli Dergi) Creative Commons License

59. Magnetic resonance image-guided adaptive stereotactic body radiotherapy for prostate cancer: preliminary results of outcome and toxicity.

Ugurluer G., Atalar B., Zoto M., Gungor G., Aydin G., Sengoz M., et al.
The British journal of radiology , cilt.94, sa.1117, ss.20200696, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

60. Time Analysis of Online Adaptive Magnetic Resonance-Guided Radiation Therapy Workflow According to Anatomical Sites.

Güngör G., Serbez İ., Temur B., Gür G., Kayalılar N., Mustafayev T., et al.
Practical radiation oncology , cilt.11, sa.1, 2021 (SCI-Expanded, Scopus)

61. Risk of Symptomatic Radiation Necrosis Following Stereotactic Radiosurgery for Brain Metastases

Sayan M., ŞAHİN B., Mustafayev T. Z., Kefelioglu E. S. S., Vergalasova I., Gupta A., et al.
RADIOTHERAPY AND ONCOLOGY , cilt.152, 2020 (SCI-Expanded, Scopus)

62. Prognostic factors in medically inoperable early stage lung cancer patients treated with stereotactic ablative radiation therapy (SABR): Turkish Radiation Oncology Society Multicentric Study

Sahin B., ATALAR B., Kaytan Saglam E., Akgun Z., ABACIOGLU M. U., Arifoglu A., et al.
CLINICAL RESPIRATORY JOURNAL , cilt.14, sa.11, ss.1050-1059, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

63. Patient-Reported Tolerance of Magnetic Resonance-Guided Radiation Therapy.

Sayan M., Serbez I., Teymur B., Gur G., Zoto Mustafayev T., Gungor G., et al.
Frontiers in oncology , cilt.10, ss.1782, 2020 (SCI-Expanded, Scopus) Creative Commons License

64. Management of symptomatic radiation necrosis after stereotactic radiosurgery and clinical factors for treatment response.

Sayan M., Mustafayev T. Z., Balmuk A., Mamidanna S., Kefelioglu E. S. S., GUNGOR G., et al.
Radiation oncology journal , cilt.38, sa.3, ss.176-180, 2020 (Hakemli Dergi) Creative Commons License

65. Corrigendum to "The impact of total neo-adjuvant treatment on nonoperative management in patients with locally advanced rectal cancer: The evaluation of 66 cases in a single center" [Eur. J. Surg. Oncol. 46/3 (2019) 402-409].

O A., H T., B B., G D., E O., B A., et al.
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY , cilt.46, sa.3, ss.402-409, 2020 (SCI-Expanded, Scopus)

66. Magnetic Resonance–Guided Radiation Therapy to Boost Cervical Cancer When Brachytherapy Is Not Available: A Case Report

Sayan M., Mustafayev T. Z., ATALAR B., GÜNGÖR G., ÖZYAR E.
Advances in Radiation Oncology , cilt.5, sa.5, ss.1066-1070, 2020 (Hakemli Dergi) Sürdürülebilir Kalkınma

67. Long-term toxicity and survival outcomes after stereotactic ablative radiotherapy for patients with centrally located thoracic tumors

Atalar B., Mustafayev T., Sio T., Sahin B., Gungor G., Aydın G., et al.
Radiology and Oncology , cilt.54, sa.4, ss.480-487, 2020 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma

68. The impact of total neo-adjuvant treatment on nonoperative management in patients with locally advanced rectal cancer: The evaluation of 66 cases

Asoglu O., Tokmak H., BAKIR B., Demir G., Ozyar E., Atalar B., et al.
EJSO , cilt.46, sa.3, ss.402-409, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

69. Multichannel Film Dosimetry for Quality Assurance of Intensity Modulated Radiotherapy Treatment Plans Under 0.35 T Magnetic Field

Gungor G., Korkmaz L., Kayalilar N., Aydin G., Yapici B., Mustafayev T. Z., et al.
CUREUS , cilt.12, 2020 (Hakemli Dergi)

70. First 500 Fractions Delivered with a Magnetic Resonance-guided Radiotherapy System: Initial Experience

Sahin B., Zoto M., Gungor G., Aydin G., Yapici B., Atalar B., et al.
CUREUS , cilt.11, sa.12, 2019 (SCI-Expanded) Creative Commons License

71. Evaluation of response to stereotactic radiosurgery in patients with radioresistant brain metastases

Sayan M., Zoto M., Sahin B., Kefelioglu E., Wang S., Kurup V., et al.
RADIATION ONCOLOGY JOURNAL , cilt.37, sa.4, ss.265-270, 2019 (Hakemli Dergi)

72. International Guideline on Dose Prioritization and Acceptance Criteria in Radiation Therapy Planning for Nasopharyngeal Carcinoma

Lee A. W., Ng W. T., Pan J. J., Chiang C., Poh S. S., Choi H. C., et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS , cilt.105, sa.3, ss.567-580, 2019 (SCI-Expanded, Scopus) Creative Commons License

73. Nüks Rektum Kanserinde İntraoperatif Radyoterapi

BİLGİN İ. A., AYTAÇ E., ERENLER B. İ., ŞAHİN B., ATALAR B., BEŞE F. N., et al.
Acıbadem Sağlık Bilimleri Dergisi , cilt.10, sa.3, ss.473-477, 2019 (TRDizin) Sürdürülebilir Kalkınma

74. Cutaneous lupus erythematosus induced by radiotherapy for breast carcinoma.

Durmaz E., ATALAR B., SEZER E., ÖZYAR E., Cetin E. D.
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG , cilt.17, sa.8, ss.832-833, 2019 (SCI-Expanded, Scopus)

75. Strahlentherapie bei Brustkrebs löst kutanen Lupus erythematodes aus.

Öztürk D., Atalar B., Sezer E., Özyar E., Dikicioǧlu Ç.
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG , cilt.17, ss.832-833, 2019 (SCI-Expanded, Scopus)

76. Dealing with the gray zones in the management of gastric cancer: The consensus statement of the Istanbul Group

AYTAÇ E., Aslan F., ÇİÇEK B., Erdamar S., Gurses B., GÜVEN K., et al.
TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.30, sa.7, ss.584-598, 2019 (SCI-Expanded, Scopus, TRDizin) Creative Commons License Sürdürülebilir Kalkınma

77. Paraganglioma of the head and neck region, treated with radiation therapy, a Rare Cancer Network study

Lassen-Ramshad Y., Ozyar E., ALANYALI S., Poortmans P., van Houtte P., Sohawon S., et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK , cilt.41, sa.6, ss.1770-1776, 2019 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

78. Nazofarenks kanserinde EBV DNA : Tanı, prognoz,tayini, tedavi kararı ve takipte yeri

Özyar E., Uğurluer G.
Kanser Gündemi , cilt.7, sa.2, ss.34-41, 2019 (Hakemsiz Dergi) Sürdürülebilir Kalkınma

79. Output factors of ionization chambers and solid state detectors for mobile intraoperative radiotherapy (IORT) accelerator electron beams

Gungor G., Aydin G., Mustafayev T. Z., ÖZYAR E.
JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS , cilt.20, sa.2, ss.13-23, 2019 (SCI-Expanded, Scopus)

80. Toxicities and Survival after Stereotactic Ablative Radiotherapy (SABR) for Centrally Located Lung Tumors

Atalar B., Mustafayev T., Sio T., Sahin B., Gungor G., Aydin G., et al.
JOURNAL OF THORACIC ONCOLOGY , cilt.13, sa.10, 2018 (SCI-Expanded, Scopus)

81. Results of Stereotactic Radiation Therapy (SABR) in Early Stage Lung Cancer: Turkish Radiation Oncology Group (TROG) Study

Atalar B., KAYTAN SAĞLAM E., Akgun Z., ABACIOGLU M. U., Arifoglu A., Sahin B., et al.
JOURNAL OF THORACIC ONCOLOGY , cilt.13, sa.10, 2018 (SCI-Expanded, Scopus)

82. Robotic radiosurgery of head and neck paragangliomas: a single institution experience

Tosun I., Atalar B., Sahin B., GÜNGÖR G., Aydin G., Yapici B., et al.
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY , cilt.14, sa.2, 2018 (SCI-Expanded, Scopus)

83. Impact of Rectal Balloon and MRI Delineation on Anorectal Dose and Gastrointestinal Toxicity Levels

GÜNGÖR G., Aydin G., Ozyar E.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS , cilt.100, sa.5, ss.1291, 2018 (SCI-Expanded, Scopus)

84. Treatment outcome and prognostic factors for adult patients with medulloblastoma: The Rare Cancer Network (RCN) experience

ATALAR B., Ozsahin M., Call J., Napieralska A., Kamer S., Villa S., et al.
RADIOTHERAPY AND ONCOLOGY , cilt.127, sa.1, ss.96-102, 2018 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

85. Concurrent cisplatin and radiotherapy versus cetuximab and radiotherapy, an unsolved problem

Guler O. C., Onal C., Ozyar E.
ANNALS OF ONCOLOGY , cilt.29, sa.3, ss.779, 2018 (SCI-Expanded, Scopus)

86. Improvement of conformal arc plans by using deformable margin delineation method for stereotactic lung radiotherapy

GÜNGÖR G., Demir M., Aydin G., Yapici B., Atalar B., Ozyar E.
JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS , cilt.19, sa.1, ss.184-193, 2018 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

87. International guideline for the delineation of the clinical target volumes (CTV) for nasopharyngeal carcinoma

Lee A. W., Ng W. T., Pan J. J., Poh S. S., Ahn Y. C., AlHussain H., et al.
RADIOTHERAPY AND ONCOLOGY , cilt.126, sa.1, ss.25-36, 2018 (SCI-Expanded, Scopus)

88. Clinical Utility of Epstein-Barr Virus DNA Testing in the Treatment of Nasopharyngeal Carcinoma Patients

Mustafayev T. Z., Ozyar E.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS , cilt.99, sa.5, ss.1306-1307, 2017 (SCI-Expanded, Scopus)

89. Non-small Cell Lung Cancer with Multiple Brain Metastases Treated with Radiosurgery and Erlotinib: A Case Report

Sahin B., Mustafayev T., Aydin G., GÜNGÖR G., Yapici B., Atalar B., et al.
CUREUS , cilt.9, sa.12, 2017 (Hakemli Dergi) Creative Commons License Sürdürülebilir Kalkınma

90. Serviks Kanserinde Türkiyedeki Sağkalım: 16 Merkezin ortak sonuçları

AKMANSU M., AKSU M. G., AKSU M. G., ALANYALI S., ARAS A. B., ASLAY I., et al.
TURKISH JOURNAL of ONCOLOGY , cilt.32, sa.1, ss.7-10, 2017 (ESCI)

91. Correlation between PET/CT primary tumor FDG uptake and lymph node metastases in cervical cancer

UĞURLUER G., ATALAR B., Ikizler H. A. S., Sozer N., Kibar M., Serin M., et al.
RADIOTHERAPY AND ONCOLOGY , cilt.123, 2017 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

92. Serviks Kanser,nde Türkiye’xxdeki sağkalım Sonuçları

AKMANSU M., AKSU M. G., AKSU M. G., ALANYALI S., ARAS A. B., aslay I., et al.
Turkish Journal Of Oncology , cilt.32, sa.Supp1, ss.7-10, 2017 (TRDizin)

93. Serviks Kanserinde Türkiye’deki Sağkalım: 16 Merkezin Ortak Sonuçları

AKMANSU M., AKSU M. G., AKSU M. G., ALANYALI S., ARAS A. B., ASLAY I., et al.
Turkish Journal of Oncology , cilt.32, sa.1, ss.7-10, 2017 (Hakemli Dergi)

94. Akciğer Kanseri SBRT Uygulamalarının RTOG 0915 Protokolüne Uygun Doz Sınırlamalarına Göre Oluşturulan 3B Konformal Ark ve VMAT SBRT Planlarının Karşılaştırılması

BAŞLANGIÇ B., GÜNGÖR G., AYDIN G., ULUER M., KARADEMİR M., YAPICI B., et al.
Acıbadem Üniversitesi Sağlık Bilimleri Dergisi , cilt.8, sa.3, ss.146-149, 2017 (Hakemli Dergi)

95. Re-Irradiation of Non-Small Cell Lung Cell Cancer Recurrences with Stereotactic Body Radiotherapy

Atalar B., Sahin B., Gungor G., Aydin G., Yapici B., Ozyar E.
JOURNAL OF THORACIC ONCOLOGY , cilt.12, sa.1, 2017 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

96. Carotid blowout syndrome after intensity-modulated radiation therapy: A case report

Sahin B., Atalar B., Yakupoglu A., Ozyar E.
MARMARA MEDICAL JOURNAL , cilt.30, sa.2, ss.124-129, 2017 (Hakemli Dergi) Creative Commons License

97. Prognostic role of negative plasma EBV DNA level in patients with NPC

Ozyar E.
ORAL ONCOLOGY , cilt.63, 2016 (SCI-Expanded, Scopus)

98. Linguistic Validation of the Turkish Version of the MD Anderson Symptom Inventory - Head and Neck Cancer Module

Gunn G. B., Atalar B., Mendoza T. R., Cleeland C. S., Selek U., Ozyar E., et al.
BALKAN MEDICAL JOURNAL , cilt.33, sa.3, ss.339-343, 2016 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma

99. The present and future opportunities of the Rare Cancer Network an international consortium for advancement of oncologic care

Sio T., Mirimanoff R., ÖZYAR E., Belkacemi Y., Miller R., Villa S., et al.
Rare Tumors , 2015 (Hakemli Dergi) Sürdürülebilir Kalkınma

100. Treatment of olfactory neuroblastoma: a new approach

Vucinic N., Eric M., Ergin T., Ozyar E., Vuckovic N.
ACTA NEUROLOGICA BELGICA , cilt.115, sa.2, ss.195-198, 2015 (SCI-Expanded, Scopus)

101. The present and future opportunities of the Rare Cancer Network: an international consortium for advancement of oncologic care

Sio T. T., Mirimanoff R., ÖZYAR E., Belkacemi Y., Miller R. C., Villa S., et al.
RARE TUMORS , cilt.7, sa.3, ss.136-141, 2015 (ESCI, Scopus)

102. An unusual case of mammary gland-like carcinoma of vulva: case report and review of literature

Baykal C., Dunder I., Turkmen I. C., Ozyar E.
EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY , cilt.36, sa.3, ss.333-334, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

103. [RCN, Rare Cancer Network].

Mirimanoff R., Thariat J., Belkacemi Y., Villa S., Ozyar E., Krengli M., et al.
Bulletin du cancer , cilt.101, ss.778-9, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

104. The international network of rare cancers (RCN, Rare Cancer Network)

Mirimanoff R., Thariat J., Beikacemi Y., Villa S., Ozyar E., Krengli M., et al.
BULLETIN DU CANCER , cilt.101, sa.9, ss.778-779, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

105. Untitled

Ozyar E., Adler J. R.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS , cilt.85, sa.1, ss.12, 2013 (SCI-Expanded, Scopus)

106. High daily fraction dose external radiotherapy for T1 glottic carcinoma: Treatment results and prognostic factors

GÜLTEKİN M., Ozyar E., CENGİZ M., ÖZYİĞİT G., Hayran M., Hosal S., et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK , cilt.34, sa.7, ss.1009-1014, 2012 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

107. Dosimetric Comparison of Robotic and Conventional Linac-Based Stereotactic Lung Irradiation in Early-Stage Lung Cancer

Atalar B., Aydin G., Gungor G., Caglar H., Yapici B., Ozyar E.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT , cilt.11, sa.3, ss.249-255, 2012 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

108. In regard to Zhou et al "Baseline Serum Lactate Dehydrogenase Levels for Patients Treated With Intensity-Modulated Radiotherapy for Nasopharyngeal Carcinoma: A Predictor of Poor Prognosis and Subsequent Liver Metastasis" (Int J Radiat Oncol Biol Phys 2012;82:e359-e365)

Ozyar E., Caglar H. B., Atalar B.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS , cilt.83, sa.2, ss.482-483, 2012 (SCI-Expanded, Scopus)

109. Use of volumetric modulated arc radiotherapy in patients with early stage glottic cancer

Atalar B., Gungor G., Caglar H., Aydin G., Yapici B., Ozyar E.
TUMORI , cilt.98, sa.3, ss.331-336, 2012 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

110. STEREOTACTIC RADIOTHERAPY OF PRIMARY LUNG CANCER AND OTHER TARGETS: RESULTS OF CONSULTANT MEETING OF THE INTERNATIONAL ATOMIC ENERGY AGENCY (INT J RADIAT ONCOL BIOL PHYS 2011;79:660-669)

Atalar B., Caglar H., Ozyar E.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS , cilt.82, sa.2, ss.521, 2012 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

111. Comparisons of static 7 field and dynamic conformal arc techniques for stereotactic lung radiotherapy Stereotaktik akciǧer ışınlamalarında statik 7 alan ve dinamik konformal ark tekniklerinin karşılaştırılması

ATALAR B., Küçükmorkoç E., Doyuran M., Güngör G., Aydin G., Yapici B., et al.
Turk Onkoloji Dergisi , cilt.27, sa.3, ss.111-118, 2012 (SCI-Expanded, Scopus)

112. Protocols for Gynecologic Radiotherapy and Brachytherapy in Acibadem Health Group and Acibadem University Hospitals Departments of Radiation Oncology VE4DH001A

Garipagaoglu M., Tezcanli E. K., Atalar B., Ugurluel G., Ucar K., Sozen N., et al.
TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY , cilt.27, sa.1, ss.1-3, 2012 (ESCI, Scopus)

113. Acıbadem Sağlık Grubu ve Acıbadem Üniversitesi Hastaneleri radyasyon onkolojisi bölümleri jinekolojik radyoterapi ve brakiterapi protokolleri

GARİPAĞAOĞLU M., TEZCANLI TJON A MEEUW E. K., ATALAR B., UĞURLUER G., UÇAR K., SOZER N., et al.
Türk Onkoloji Dergisi , 2012 (Hakemli Dergi)

114. Prognostic significance of tumor volume in nasopharyngeal carcinoma

Sarisahin M., Cila A., Ozyar E., YILDIZ F., Turen S.
AURIS NASUS LARYNX , cilt.38, sa.2, ss.250-254, 2011 (SCI-Expanded, Scopus)

115. Treatment results and prognostic factors in primary thyroid lymphoma patients: a Rare Cancer Network study

Onal C., Li Y. X., Miller R. C., Poortmans P., Constantinou N., Weber D. C., et al.
ANNALS OF ONCOLOGY , cilt.22, sa.1, ss.156-164, 2011 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

116. Retrospective analysis of patients treated in the Istanbul CyberKnife Coalition Centers

ATALAR B., Kocak M., Ozseker N., Kucuk N., Dagoglu N., ÖZYAR E., et al.
TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY , cilt.26, sa.3, ss.101-107, 2011 (Hakemli Dergi) Sürdürülebilir Kalkınma

117. Adult langerhans cell histiocytosis of bones : a rare cancer network study.

Atalar B., Miller R. C., Dincbas F. O., Geismar J. H., Micke O., Akyurek S., et al.
Acta orthopaedica Belgica , cilt.76, sa.5, ss.663-8, 2010 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

118. Adult Langerhans cell histiocytosis of bones : A rare cancer network study

Atalar B., Miller R. C., DİNÇBAŞ H. F., Geismar J. H., Micke O., AKYÜREK S., et al.
ACTA ORTHOPAEDICA BELGICA , cilt.76, sa.5, ss.663-668, 2010 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

119. Intensity modulated radiotherapy (IMRT) in bilateral retinoblastoma

ATALAR B., ÖZYAR E., GÜNDÜZ K., Gungor G.
RADIOLOGY AND ONCOLOGY , cilt.44, sa.3, ss.194-198, 2010 (SCI-Expanded, Scopus)

120. T4N0M0 nasopharyngeal carcinoma patients: do they have a distinct tumor biology?

Atasoy B. M., Ozyar E., Akman F., Esassolak M., Abacioǧlu U.
Kulak burun boǧaz ihtisas dergisi : KBB = Journal of ear, nose, and throat , cilt.20, sa.2, ss.89-96, 2010 (Scopus, TRDizin)

121. PEDIATRIC AND YOUNG ADULT NASOPHARYNGEAL CARCINOMA PATIENTS TREATED WITH PRERADIATION CISPLATIN AND DOCETAXEL CHEMOTHERAPY

VARAN A., Oezyar E., Corapcioglu F., Koeksal Y., Aydin B., Yazici N., et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS , cilt.73, sa.4, ss.1116-1120, 2009 (SCI-Expanded, Scopus)

122. The treatment of childhood Hodgkin lymphoma: Improved survival in a developing country

Bueyuekpamukcu M., VARAN A., Akyuez C., Atahan L., Oezyar E., Kale G., et al.
ACTA ONCOLOGICA , cilt.48, sa.1, ss.44-51, 2009 (SCI-Expanded, Scopus)

123. Vaginal high dose rate brachytherapy alone in patients with intermediate- to high-risk stage I endometrial carcinoma after radical surgery.

Atahan I. L., Ozyar E., YILDIZ F., ÖZYİĞİT G., Genc M., Ulger S., et al.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society , cilt.18, sa.6, ss.1294-9, 2008 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

124. Effect of bladder distension on dose distribution of intracavitary brachytherapy for cervical cancer: Three-dimensional computed tomography plan evaluation

CENGİZ M., Gurdalli S., Selek U., YILDIZ F., Saglam Y., Ozyar E., et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS , cilt.70, sa.2, ss.464-468, 2008 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

125. Long-term outcome and prognostic factors in patients with cervical carcinoma: a retrospective study

Atahan I. L., Onal C., Ozyar E., Yiliz F., Selek U., Kose F.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER , cilt.17, sa.4, ss.833-842, 2007 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

126. Use of plasma Epstein-Barr virus DNA monitoring as a tumor marker in follow-up of patients with nasopharyngeal carcinoma: Preliminary results and report of two cases

Oezyar E., Gueltekin A., Alp A., Hascelik G., Ugur O., Atahan I. L.
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS , cilt.22, sa.3, ss.194-199, 2007 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

127. Radiotherapy in the adjuvant setting of cervical carcinoma: treatment, results, and prognostic factors

Atahan I. L., Yildiz F., ÖZYAR E., Pehlivan B., Genc M., KÖSE M. F., et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER , cilt.17, sa.4, ss.813-820, 2007 (SCI-Expanded, Scopus)

128. Treatment of pediatric nasopharyngeal cancer

Oezyar E.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY , cilt.29, 2007 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

129. Bimodal age distribution in Hodgkin's disease and nasopharyngeal carcinoma

Barista I., Varan A., Ozyar E.
MEDICAL HYPOTHESES , cilt.68, sa.6, ss.1421, 2007 (SCI-Expanded, Scopus)

130. Incidence of hypothyroidism after radiotherapy for nasopharyngeal carcinoma

Ulger S., Ulger Z., Yildiz F., Ozyar E.
MEDICAL ONCOLOGY , cilt.24, sa.1, ss.91-94, 2007 (SCI-Expanded, Scopus)

131. Treatment results of 165 pediatric patients with non-metastatic nasopharyngeal carcinoma: A Rare Cancer Network study

ÖZYAR E., Selek U., Laskar S., Uzel O., Anacak Y., Ben-Arush M., et al.
RADIOTHERAPY AND ONCOLOGY , cilt.81, sa.1, ss.39-46, 2006 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

132. Radiotherapy in the treatment of mucosal melanoma of the upper aerodigestive tract: Analysis of 74 cases. A rare cancer network study

Krengli M., Masini L., Kaanders J. H. A. M., Maingon P., Oei S. B., Zouhair A., et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS , cilt.65, sa.3, ss.751-759, 2006 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

133. Radiotherapy in the management of Kaposi's sarcoma: Comparison of 8 Gy versus 6 Gy

Yildiz F., Genc M., Akyurek S., Cengiz M., Ozyar E., Selek U., et al.
JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION , cilt.98, sa.7, ss.1136-1139, 2006 (SCI-Expanded, Scopus)

134. Treatment results of 84 patients with nasopharyngeal carcinoma in childhood

Kupeli S., Varan A., Ozyar E., Atahan I., Yalcin B., Kutluk T., et al.
PEDIATRIC BLOOD & CANCER , cilt.46, sa.4, ss.454-458, 2006 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

135. Mold brachytherapy in Bowen's disease: a case report and review of the literature

HÜRMÜZ P., ERSOY EVANS S., Yapici B., Gurdalli S., Saglam Y., ŞAHİN S., et al.
TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY , cilt.21, sa.2, ss.102-106, 2006 (SCI-Expanded, TRDizin)

136. Assessment of quality of life of nasopharyngeal carcinoma patients with EORTC QLQ-C30 and H&N-35 modules

Cengiz M., ÖZYAR E., Esassolak M., Altun M., Akmansu M., ŞEN M., et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS , cilt.63, sa.5, ss.1347-1353, 2005 (SCI-Expanded, Scopus)

137. Trismus as a presenting symptom in nasopharyngeal carcinoma

Ozyar E., Cengiz M., Gurkaynak M., Atahan I.
RADIOTHERAPY AND ONCOLOGY , cilt.77, sa.1, ss.73-76, 2005 (SCI-Expanded, Scopus)

138. Post-operative radiotherapy in advanced laryngeal cancer: effect on local and regional recurrence, distant metastases and second primaries

Yilmaz T., Hosal S., Ozyar E., Akyol F., Gursel B.
JOURNAL OF LARYNGOLOGY AND OTOLOGY , cilt.119, sa.10, ss.784-790, 2005 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

139. Classical Kaposi's Sarcoma: efficacy of single high dose radiotherapy

Yildiz F., Genc M., Cengiz M., ÖZYAR E., Akbulut S., Hurmuz P., et al.
EJC SUPPLEMENTS , cilt.3, sa.2, ss.351-352, 2005 (SCI-Expanded, Scopus)

140. Treatment results of 59 young patients with nasopharyngeal carcinoma

Selek U., Ozyar E., Ozyigit G., Varan A., Buyukpamukcu M., Atahan I.
INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY , cilt.69, sa.2, ss.201-207, 2005 (SCI-Expanded, Scopus)

141. Induction chemotherapy with cisplatin and 5-fluorouracil followed by chemoradiotherapy or radiotherapy alone in the treatment of locoregionally advanced resectable cancers of the larynx and hypopharynx: Results of single-center study of 45 patients

Altundag O., Gullu I., Altundag K., Yalcin S., Ozyar E., Cengiz M., et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK , cilt.27, sa.1, ss.15-21, 2005 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

142. Unusual, hypersensitivity to radiation therapy in a patient with dyskeratosis congenita syndrome

Cengiz M., Ozyar E., Atahan I., Celebioglu B.
ORAL ONCOLOGY , cilt.40, sa.7, ss.758-759, 2004 (SCI-Expanded, Scopus)

143. Non-metastatic stage IV nasopharyngeal carcinoma patients: analysis of the pattern of relapse and survival

Ozyar E., Gurkaynak M., Yildiz F., Atahan I.
RADIOTHERAPY AND ONCOLOGY , cilt.72, sa.1, ss.71-77, 2004 (SCI-Expanded, Scopus)

144. Prognostic role of Ebstein-Barr virus latent membrane protein-1 and Interleukin-10 expression in patients with nasopharyngeal carcinoma

Ozyar E., Ayhan A., Korcum A., Atahan I.
CANCER INVESTIGATION , cilt.22, sa.4, ss.483-491, 2004 (SCI-Expanded, Scopus)

145. Salvage ifosfamide-doxorubicin chemotherapy in patients with recurrent nasopharyngeal carcinoma pretreated with cisplatin-based chemotherapy

Altundag K., Aksoy S., Gullu I., Altundag O., Ozyar E., Yalcin S., et al.
MEDICAL ONCOLOGY , cilt.21, sa.3, ss.211-215, 2004 (SCI-Expanded, Scopus)

146. Frequency of skeletal metastases in nasopharyngeal carcinoma after initiation of therapy: should bone scans be used for follow-up?

Caglar M., Ceylan E., Ozyar E.
NUCLEAR MEDICINE COMMUNICATIONS , cilt.24, sa.12, ss.1231-1236, 2003 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

147. Waldeyer's ring lymphomas - Treatment results and prognostic factors

Gurkaynak M., Cengiz M., AKYÜREK S., ÖZYAR E., Atahan I., Tekuzman G.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS , cilt.26, sa.5, ss.437-440, 2003 (SCI-Expanded, Scopus)

148. Mold brachytherapy can be an optional technique for total scalp irradiation

Ozyar E., Gurdalli S.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS , cilt.54, sa.4, ss.1286, 2002 (SCI-Expanded, Scopus)

149. Is there a survival benefit to adjuvant radiotherapy in high-risk surgical stage I endometrial cancer?

Ayhan A., Taskiran C., Celik C., Guney I., Yuce K., Ozyar E., et al.
GYNECOLOGIC ONCOLOGY , cilt.86, sa.3, ss.259-263, 2002 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

150. Adjuvant high-dose-rate brachytherapy after external beam radiotherapy in nasopharyngeal carcinoma

Ozyar E., Yildz F., Akyol F., Atahan I.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS , cilt.52, sa.1, ss.101-108, 2002 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

151. Outcome of abducens nerve paralysis in patients with nasopharyngeal carcinoma

Ilhan O., Sener E., Ozyar E.
EUROPEAN JOURNAL OF OPHTHALMOLOGY , cilt.12, sa.1, ss.55-59, 2002 (SCI-Expanded, Scopus)

152. Radiotherapy in the management of Kasabach-Merritt syndrome: A case report

Atahan I., Cengiz M., Ozyar E., Gurkaynak M.
PEDIATRIC HEMATOLOGY AND ONCOLOGY , cilt.18, sa.7, ss.471-476, 2001 (SCI-Expanded, Scopus)

153. In regard to Altun et al.

Ozyar E.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS , cilt.49, sa.3, ss.900-901, 2001 (SCI-Expanded, Scopus)

154. Malignancy in Behcet's disease: A report of 13 cases and a review of the literature

Cengiz M., Altundag M., Zorlu A., Gullu I., Ozyar E., Atahan I.
CLINICAL RHEUMATOLOGY , cilt.20, sa.4, ss.239-244, 2001 (SCI-Expanded, Scopus)

155. Two cases of Stevens-Johnson syndrome: toxic epidermal necrolysis possibly induced by amifostine during radiotherapy

Atahan I., Ozyar E., Sahin S., Yildiz F., Yalcin B., Karaduman A.
BRITISH JOURNAL OF DERMATOLOGY , cilt.143, sa.5, ss.1072-1073, 2000 (SCI-Expanded, Scopus)

156. Caution on the use of altered fractionation for nasopharyngeal carcinoma - comment

Ozyar E., Atahan I.
RADIOTHERAPY AND ONCOLOGY , cilt.54, sa.3, ss.283-284, 2000 (SCI-Expanded, Scopus)

157. Organ preservation by induction chemotherapy plus radiotherapy in locally advanced larynx and hypopharynx cancers: Preliminary results.

Gullu Y., Altundag M., Yalcin S., Altundag O., Tekuzman G., Ozyar E., et al.
ANNALS OF ONCOLOGY , cilt.11, ss.94, 2000 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

158. High dose rate mold brachytherapy of early gingival carcinoma: A clinical report

Cengiz M., Ozyar E., Ersu B., Akyol F., Atahan I.
JOURNAL OF PROSTHETIC DENTISTRY , cilt.82, sa.5, ss.512-514, 1999 (SCI-Expanded, Scopus)

159. Acute phase response during radiotherapy

Cengiz M., Akbulut S., Ozturk D., Ozyar E., Atahan I.
EUROPEAN JOURNAL OF CANCER , cilt.35, 1999 (SCI-Expanded, Scopus)

160. Comparison of AJCC 1988 and 1997 classifications for nasopharyngeal carcinoma

Ozyar E., Yildiz F., Akyol F., Atahan I.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS , cilt.44, sa.5, ss.1079-1087, 1999 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

161. Sucralfate in the prevention of radiation-induced oral mucositis

Cengiz M., Ozyar E., Ozturk D., Akyol F., Atahan I., Hayran M.
JOURNAL OF CLINICAL GASTROENTEROLOGY , cilt.28, sa.1, ss.40-43, 1999 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

162. Choroid metastasis of undifferentiated nasopharyngeal carcinoma

Ozyar E., Kiratli H., Akbulut S., Uzal D., Atahan I.
JOURNAL OF LARYNGOLOGY AND OTOLOGY , cilt.112, sa.7, ss.667-669, 1998 (SCI-Expanded, Scopus)

163. Reduced incidence of the somnolence syndrome after prophylactic cranial irradiation in children with acute lymphoblastic leukemia

Uzal D., Ozyar E., Hayran M., Zorlu F., Atahan L., Yetkin S.
RADIOTHERAPY AND ONCOLOGY , cilt.48, sa.1, ss.29-32, 1998 (SCI-Expanded, Scopus)

164. A hinged flange radiation carrier for the scalp: A clinical report

Ersu B., Hekimoglu C., Ozyar E., Aslan Y.
JOURNAL OF PROSTHETIC DENTISTRY , cilt.79, sa.4, ss.369-371, 1998 (SCI-Expanded, Scopus)

165. Basal cell carcinomas developing in a case of medulloblastoma associated with Gorlin's syndrome

Atahan I., Yildiz F., Ozyar E., Uzal D., Zorlu F.
PEDIATRIC HEMATOLOGY AND ONCOLOGY , cilt.15, sa.2, ss.187-191, 1998 (SCI-Expanded, Scopus)

166. Monitoring response to therapy with thallium-201 and technetium-99m-sestamibi SPECT in nasopharyngeal carcinoma

Kostakoglu L., Uysal U., Ozyar E., Hayran M., Uzal D., Demirkazik F., et al.
JOURNAL OF NUCLEAR MEDICINE , cilt.38, sa.7, ss.1009-1014, 1997 (SCI-Expanded, Scopus)

167. A comparative study of technetium-99m sestamibi and technetium-99m tetrofosmin single-photon tomography in the detection of nasopharyngeal carcinoma

Kostakoglu L., Uysal U., Ozyar E., Demirkazik F., Hayran M., Atahan L., et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE , cilt.24, sa.6, ss.621-628, 1997 (SCI-Expanded, Scopus)

168. Kaposi's sarcoma: The efficacy of a single fraction of 800 cGy

Yildiz F., Ozyar E., Uzal D., Sahin S., Atahan I.
DERMATOLOGY , cilt.195, sa.2, ss.142-144, 1997 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

169. Pre- and post-therapy thallium-201 and technetium-99m-sestamibi SPECT in nasopharyngeal carcinoma

Kostakoglu L., Uysal U., Ozyar E., Elahi N., Hayran M., Uzal D., et al.
JOURNAL OF NUCLEAR MEDICINE , cilt.37, sa.12, ss.1956-1962, 1996 (SCI-Expanded, Scopus)

170. Determination of the diagnostic potentials of Tl-201 and Tc-99m-Sestamibi (MIBI) during pre- and post-therapy evaluation in nasopharyngeal carcinoma.

Kostakoglu L., Uysal U., Ozyar E., Hayran M., Uzal D., Caner B., et al.
JOURNAL OF NUCLEAR MEDICINE , cilt.37, sa.5, ss.1153, 1996 (SCI-Expanded, Scopus)

171. Major toxicity of cisplatin, fluorouracil, and leucovorin following chemoradiotherapy in patients with nasopharyngeal carcinoma

Celik I., Kars A., Ozyar E., Tekuzman G., Atahan L., Firat D.
JOURNAL OF CLINICAL ONCOLOGY , cilt.14, sa.3, ss.1043-1044, 1996 (SCI-Expanded, Scopus)

172. A CASE OF MUCOEPIDERMOID CARCINOMA OF THE PAROTID-GLAND DEVELOPING IN A CHILD AFTER THE TREATMENT OF ACUTE LYMPHOBLASTIC-LEUKEMIA

ATAHAN I., AYHAN A., OZYAR E., ERTOY D., GURKAYNAK M.
PEDIATRIC HEMATOLOGY AND ONCOLOGY , cilt.12, sa.4, ss.403-405, 1995 (SCI-Expanded, Scopus)

173. RESULTS OF RADIOTHERAPY IN CRANIOPHARYNGIOMAS ANALYZED BY THE LINEAR-QUADRATIC MODEL

GURKAYNAK M., OZYAR E., ZORLU F., AKYOL F., ATAHAN I.
ACTA ONCOLOGICA , cilt.33, sa.8, ss.941-943, 1994 (SCI-Expanded, Scopus)

174. RESULTS OF POSTOPERATIVE OR EXCLUSIVE RADIOTHERAPY IN GRADE-I AND GRADE-II CEREBELLAR ASTROCYTOMA PATIENTS

AKYOL F., ATAHAN I., ZORLU F., GURKAYNAK M., ALANYALI H., OZYAR E.
RADIOTHERAPY AND ONCOLOGY , cilt.23, sa.4, ss.245-248, 1992 (SCI-Expanded, Scopus)

175. A LOCALIZED HYPERSENSITIVITY REACTION TO CO-TRIMOXAZOLE IN A PREVIOUSLY IRRADIATED FIELD SIMULATING A RECALL PHENOMENON

ATAHAN I., AKYOL F., GURKAYNAK M., ALANYALI H., OZYAR E.
BRITISH JOURNAL OF RADIOLOGY , cilt.62, sa.744, ss.1107-1108, 1989 (SCI-Expanded, Scopus)
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 55

1. Stereotactic Ablative MR-Guided Online Adaptive Radiation Therapy (SMART) for Management of Borderline Resectable and Locally Advanced Pancreatic Carcinoma

Dincer N., Atahan C., Gungor G., Mustafayev T. Z., UĞURLUER G., ABACIOGLU M. U., et al.
67th Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO), San-Francisco, Kostarika, 27 Eylül - 01 Ekim 2025, cilt.123, (Özet Bildiri)

2. Therapy Dogs Supported Radiotherapy in Cancer Patients Treated with MR Linac Preliminary Results

Kucuktulu E., ATALAR B., TOPBAŞ M., Bilir B., Bicakci A., YILMAZ K. B., et al.
66th International Conference on American-Society-for-Radiation-Oncology (ASTRO), Washington, Kiribati, 29 Eylül - 02 Ekim 2024, (Özet Bildiri)

3. Efficacy and Safety of Magnetic Resonance-Guided Online Adaptive Stereotactic Radiotherapy in Oligometastatic Gynecologic Malignancies: A Multi -Institutional Outcomes Study

Cerbon D. A., ÖZYAR E., UĞURLUER G., Tadross M., Rivera A., Albuquerque K. V., et al.
66th International Conference on American-Society-for-Radiation-Oncology (ASTRO), Washington, Kiribati, 29 Eylül - 02 Ekim 2024, cilt.120, (Özet Bildiri)

4. Breast cancer annotation across genders

Costea M., Colombo L., GUNGOR G., Klausner G., Clavier J., Leduc N., et al.
Annual Meeting of the European-Society-for-Radiotherapy-and-Oncology (ESTRO), Glasgow, İngiltere, 3 - 07 Mayıs 2024, (Özet Bildiri)

5. Outcomes of MR-Guided Stereotactic Body Radiotherapy (MRgSBRT) for Adrenal Metastases: A Multi -Institutional Pooled Analysis

UĞURLUER G., Schneiders F. L., Corradini S., Boldrini L., Kotecha R., Kelly P., et al.
65th ANNUAL MEETING OF THE AMERICAN-SOCIETY-FOR-RADIATION-ONCOLOGY (ASTRO), California, Amerika Birleşik Devletleri, 1 - 04 Ekim 2023, cilt.117, (Özet Bildiri)

6. Dosimetric Comparison of High Dose Rate Brachytherapy vs MR-Guided SBRT Boost for Cervical Cancer

DİNCER N., UĞURLUER G., Mustafayev T. Z., Serkizyan A., AYDIN G., GUNGOR G., et al.
Annual Meeting of the European-Society-for-Radiotherapy-and-Oncology (ESTRO), Vienna, Avusturya, 12 - 16 Mayıs 2023, (Özet Bildiri)

7. Patients with cardiac implantable electronic devices: A Patterns of Care Survey for low-field MRgRT

Schrader M., Schuler H. G., Kishan A., Atalar B., Boldrini L., Ehrbar S., et al.
Annual Meeting of the European-Society-for-Radiotherapy-and-Oncology (ESTRO), Vienna, Avusturya, 12 - 16 Mayıs 2023, cilt.182, (Özet Bildiri)

8. Benefit of Magnetic Resonance guided adaptive radiotherapy for treatment of pancreatic lesions

Mustafayev T. Z., UĞURLUER G., Serkizyan A., Gungor G., ATALAR B., ÖZYAR E.
Annual Meeting of the European-Society-for-Radiotherapy-and-Oncology (ESTRO), Vienna, Avusturya, 12 - 16 Mayıs 2023, (Özet Bildiri)

9. Evaluation of AI vs. Clinical Experts SBRT-Thorax Computed Tomography OARs Delineation

Stathakis S., Pissakas G., Alexiou A., Bertrand B., Bondiau P. Y., Claude L., et al.
Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO), ELECTR NETWORK, 23 - 26 Ekim 2022, (Özet Bildiri)

10. A Multi-Centric Evaluation of AI-Driven Synthetic CT Generation Form Low Field Magnetic Resonance Imaging

GUNGOR G., Azria D., Balermpas P., Boldrini L., Chuong M. D., De Ridder M., et al.
Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO), ELECTR NETWORK, 23 - 26 Ekim 2022, (Özet Bildiri)

11. MR-Guided Online Adaptive Stereotactic Body Radiotherapy (SBRT) of Primary and Metastatic Lung Tumors

UĞURLUER G., Mustafayev T. Z., ABACIOGLU M. U., GUNGOR G., ŞENGÖZ K. M., ÖZYAR E., et al.
Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO), ELECTR NETWORK, 23 - 26 Ekim 2022, (Özet Bildiri)

12. A Multi-Centric Evaluation of AI-Driven OARs Low Field MRgRT Pelvic /Abdomen Contouring

Azria D., Andratschke N., Balermpas P., Boldrini L., Bourdais R., Bruynzeel A., et al.
Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO), ELECTR NETWORK, 23 - 26 Ekim 2022, (Özet Bildiri)

13. PSA Kinetics and Outcomes after Magnetic Resonance Image-Guided Stereotactic Body Radiotherapy for Prostate Cancer

UĞURLUER G., Mustafayev T. Z., ATALAR B., GUNGOR G., Sengoz M., Abacioglu M. U., et al.
Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO), ELECTR NETWORK, 23 - 26 Ekim 2022, (Özet Bildiri)

14. A multicentre retrospective analysis of recurrent/metastatic (RM) nasopharyngeal cancer (NPC) from non-endemic areas: Results in the pre-immunotherapy era

Bossi P., Alberti A., Zamparini M., Orlandi E., Grisanti S., Trama A., et al.
Annual Meeting of the European-Society-for-Medical-Oncology (ESMO), ELECTR NETWORK, 9 - 13 Eylül 2022, (Özet Bildiri)

15. Adrenal metastazlarının tedavisinde MR kılavuzluğunda stereotaktik adaptif radyoterapinin dozimetrik ve klinik sonuçları

Uğurluer G., Serkizyan A., Zoto Mustafayev T., Atalar B., Abacıoğlu U., Şengör M., et al.
UROK 2021, Antalya, Türkiye, 26 - 30 Kasım 2021, ss.78, (Özet Bildiri)

16. Oligometastatik hastalarda karaciğer metastazlarının tedavisi için MR kılavuzluğunda online adaptif radyoterapi

Uğurluer G., Atalar B., Zoto Mustafayev T., Güngör G., Dincer N., Köken Ü., et al.
UROK 2021, Antalya, Türkiye, 26 - 30 Kasım 2021, ss.56, (Özet Bildiri)

17. Oligometastazların Tedavisinde Stereotaktik MR Kılavuzluğunda Adaptif Radyoterapinin (SMART) Çok Merkezli Sonuçları

Chuong M. D., Herrera R., Mustafayev T. Z., Güngör G., Uğurluer G., Atalar B., et al.
14. Ulusal Radyasyon Onkolojisi Kongresi, Antalya, Türkiye, 26 - 30 Kasım 2021, ss.8-9, (Özet Bildiri)

18. Prostat kanseri tedavisinde MR kılavuzluğunda online adaptif stereotaktik vücut radyoterapisi

Uğurluer G., Atalar B., Zoto Mustafayev T., Güngör G., Dincer N., Köken Ü., et al.
UROK 2021, Antalya, Türkiye, 26 - 30 Kasım 2021, ss.51, (Özet Bildiri) Sürdürülebilir Kalkınma

19. Stereotaktik beyin radyoterapisi sonrası gelişen radyonekroz tedavisine yönelik bevacizumab tedavinin etkinliği

Zoto Mustafayev T., Turna M., Bölükbaşı Y., Tezcanlı E., Güney Y., Kaydıhan N., et al.
UROK 2021, Antalya, Türkiye, 26 - 30 Kasım 2021, ss.83, (Özet Bildiri)

20. Pankreas tümörlerinin MR kılavuzluğunda online adaptif radyoterapi (SMART) ile tedavi sonuçları

Zoto Mustafayev T., Uğurluer G., Güngör G., Atalar B., Serkizyan A., Abacıoğlu U., et al.
UROK 2021, Antalya, Türkiye, 26 - 30 Kasım 2021, ss.79, (Özet Bildiri)

21. Dosimetric and Clinical Evaluation of Stereotactic MR-guided Online Adaptive Radiation Therapy (SMART) for Treatment of Adrenal Metastases

Uğurluer G., Serkizyan A., Zoto Mustafayev T., Atalar B., Abacıoğlu M. U., Güngör G., et al.
ASTRO 63rd Annual Meeting, Illinois, Amerika Birleşik Devletleri, 24 - 27 Ekim 2021, ss.27, (Özet Bildiri)

22. ERKEN EVRE GLOTTİK KANSERLERDE KAROTİSKORUYUCU RADYOTERAPİ SONUÇLARI:TROD BAŞ-BOYUN KANSERLERİ GRUBU ÇALIŞMASI

CEYLANER BIÇAKCI B., MUSTAFAYEV T. Z., ÇETİNAYAK H. O., İĞDEM M. Ş., DURU BİRGİ S., MEYDAN A. D., et al.
Türk Radyasyon Onkolojisi Derneği Sanal Kongresi, 20-22 Kasım 2020, Türkiye, 20 - 22 Kasım 2020, (Özet Bildiri) Sürdürülebilir Kalkınma

23. Feasibility of Stereotactic MR-Guided Adaptive Radiotherapy in Localized Prostate Cancer

Mustafayev T. Z., Atalar B., Gungor G., Sengoz M., Abacioglu U., Ozyar E.
62nd Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO), ELECTR NETWORK, 25 - 28 Ekim 2020, cilt.108, (Özet Bildiri) Sürdürülebilir Kalkınma

24. Outcomes Of Carotid Sparing Radiotherapy For Early Stage Glottic Cancer: Turkish Society For Radiation Oncology Group (TROD) Retrospective Study

Bicakci B. C., Mustafayev T. Z., Cetinayak O., Igdem S., Birgi S. D., Meydan D., et al.
62nd Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO), ELECTR NETWORK, 25 - 28 Ekim 2020, cilt.108, (Özet Bildiri)

25. Outcomes of carotid sparing radiotherapy for early stage glottic cancer: Turkish Society for Radiation Oncology Group (TROD) Retrospective Study

BIÇAKÇI B. C., MUSTAFAYEV T. Z., ÇETİNAYAK H. O., İĞDEM M. Ş., BİRGİ S. D., MEYDAN A. D., et al.
ASTRO 2020, MIAMI, Amerika Birleşik Devletleri, 6 - 08 Mart 2020, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

26. Survival and prognostic factors of nasopharyngeal cancer patients in non-endemic countries: A large multicentric database analysis

Bossi P., Grisanti S., Mohamad I., Linares Galiana I., ÖZYAR E., Franco P., et al.
44th Congress of the European-Society-for-Medical-Oncology (ESMO), Barcelona, İspanya, 27 Eylül - 01 Ekim 2019, cilt.30, (Özet Bildiri) Sürdürülebilir Kalkınma

27. Time Analysis in Magnetic Resonance Image-Guided Radiotherapy Workflow

Mustafayev T. Z., Sahin B., Gungor G., Aydin G., Serbez I., Teymur B., et al.
61st Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO), Illinois, Amerika Birleşik Devletleri, 15 - 18 Eylül 2019, cilt.105, (Özet Bildiri)

28. Clinical outcome and toxicity of stereotactic ablative radiotherapy to centrally located tumors.

Atalar B., Sahin B., Mustafayev T. Z., Gungor G., Aydin G., Yapici B., et al.
37th Meeting of the European-Society-for-Radiotherapy-and-Oncology (ESTRO), Barcelona, İspanya, 20 - 24 Nisan 2018, cilt.127, (Özet Bildiri)

29. Impact of plasma Epstein-Barr virus-DNA and gross tumor volume on prognosis of nasopharyngeal cancer

Mustafayev T. Z., Sahin B., Atalar B., Ozyar E.
37th Meeting of the European-Society-for-Radiotherapy-and-Oncology (ESTRO), Barcelona, İspanya, 20 - 24 Nisan 2018, cilt.127, (Özet Bildiri) Sürdürülebilir Kalkınma

30. Improvement of Conformal Arc Plans By Using Deformable Margin DelineationTechnique in Stereotactic Body Radiotherapy

Gungor G., Demir M., Aydin G., Atalar B., Yapici B., Ozyar E.
59th Annual Meeting and Exhibition of the American-Association-of-Physicists-in-Medicine (AAPM), Colorado, Amerika Birleşik Devletleri, 30 Temmuz - 03 Ağustos 2017, cilt.44, ss.2962, (Özet Bildiri)

31. Rekürren Baş-Boyun Kanserli Olgularda Stereotaktik Radyoterapi ile Reirradyasyon Sonuçları ve Karotis Blow-Out Sendromu: Türk Radyasyon Onkolojisi Grubu Çalışması

CENGİZ M., ÖZYAR E., YÜCE SARI S., ŞAHİN B., YAZICI G., ÖZYİĞİT G.
22. ULUSAL KANSER KONGRESİ, Türkiye, 19 - 23 Nisan 2017, (Özet Bildiri) Sürdürülebilir Kalkınma

32. Adenoid Kistik Karsinomlu Olgularda Radyoterapi Sonuçları: Türk Radyasyon Onkolojisi Grubu Çalışması.

ÖZYİĞİT G., AKMANSU M., YÜCE SARI S., ERPOLAT Ö. P., dizman a., ATASOY B. M., et al.
22. Ulusal Kanser Kongresi, Türkiye, 19 - 23 Nisan 2017, (Özet Bildiri)

33. Standardizing SUV Measurements and Comparing With Other Parameters to Predict Treatment Failure of Cervix Carcinoma

Guner L. A., Ozyar E., Sahin B., Atalar B., Aksoy T., Vardareli E.
Annual Congress of the European-Association-of-Nuclear-Medicine, Barcelona, İspanya, 15 - 19 Ekim 2016, cilt.43, (Özet Bildiri)

34. Outcome and prognosticators in adult patients with medulloblastoma A Rare Cancer Network study

ATALAR B., Ozsahin M., Call J., Napieralska A., KAMER E. S., Salvador V., et al.
ESTRO 35, 29 Nisan - 03 Mayıs 2016 Sürdürülebilir Kalkınma

35. Outcome and prognosticators in adult patients with medulloblastoma a Rare Cancer Network Study

ATALAR B., ÖZŞAHİN M., Napieralska A., KAMER E. S., SALVADOR V., ERPOLAT Ö. P., et al.
ESTRO 2016, 1 Nisan - 03 Mayıs 2016, (Özet Bildiri) Sürdürülebilir Kalkınma

36. Türk radyasyon Onkolojisi Derneği Pediatrik Radyoterapi Grubu Yönelim Anketi Çalışması

AĞAOĞLU F., YÜCEL S., DEMİRÖZ ABAKAY C., Alioğlu F., YÜRÜT ÇALOĞLU V., GÜLTEKİN M., et al.
XII UROK, Antalya, Türkiye, 20 - 24 Nisan 2016, ss.187, (Tam Metin Bildiri)

37. Patterns of Care Study in Turkish Nasopharyngeal Cancer Patients (NAZOTURK): A Turkish Radiation Oncology Association Head and Neck Cancer Working Group Study

ÖZYAR E., Dizman A., Esassolak M., Ikizler A., Yildirim C., Caloglu M., et al.
57th Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO), San-Antonio, Kuzey Mariana Adaları, 18 - 21 Ekim 2015, cilt.93, (Özet Bildiri) Sürdürülebilir Kalkınma

38. Comparison of Conformal and Volumetric Modulated Arc Techniques According to RTOG 0915 Protocol Treatment Planning Guidelines in Stereotactic Lung Radiation Therapy

Baslangic B., Gungor G., Atalar B., Uluer M., Karademir M., Aydin G., et al.
57th Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO), San-Antonio, Kuzey Mariana Adaları, 18 - 21 Ekim 2015, cilt.93, (Özet Bildiri)

39. Patterns of care study in Turkish nasopharyngeal cancer patients NAZOTURK A Turkish Radiation Oncology Association head and neck cancer working group study

ÖZYAR E., DIZMAN A., ESASSOLAK M., IKIZLER A., YILDIRIM C., CALOGLU M., et al.
American Society for Radiation Oncology 57th Annual Meeting, 18 - 21 Ekim 2015 Sürdürülebilir Kalkınma

40. Nazofarenks kanseri hastalarında hasta tedavi yaklaşımı Türk Radyasyon Onkolojisi Derneği baş boyun kanserleri çalışma grubu çalışması

ŞAHİN B., DİZMAN A., ESASSOLAK M. A., SARAN İKİZLER A., YILDIRIM C., ÇALOĞLU M., et al.
21. Ulusal Kanser Kongresi, Türkiye, 22 - 26 Nisan 2015 Sürdürülebilir Kalkınma

41. ROBOTIC STEREOTACTIC HYPOFRACTIONATED RADIOTHERAPY IN MENINGIOMAS

Sahin B., Atalar B., Aydin G., Gungor G., Yapici B., Ozyar E.
11th Congress of the European-Association-of-Neuro-Oncology, Turin, İtalya, 9 - 12 Ekim 2014, cilt.16, (Özet Bildiri)

42. Dose escalation with intensity modulated radiotherapy in the treatment of locally advanced cervical cancer

Caglar H., Ikizler A. S., Atalar B., Sozer N., Er O., Doruk H., et al.
European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO, Amsterdam, Hollanda, 27 Eylül - 01 Ekim 2013, cilt.49, (Özet Bildiri) Sürdürülebilir Kalkınma

43. Lokal İleri Evre Rektum Kanserinde IMRT-KT ile Total Patolojik Yanıt ve Yan Etkiler

SÖZER N., SARAN A., GÜNER O. S., TÜMAY L. V., DORUK H., BAŞKAN Z., et al.
XIV.Ulusal Kolon ve Rektum Cerrahisi Kongresi, Antalya, Türkiye, 15 - 19 Mayıs 2013, (Özet Bildiri) Sürdürülebilir Kalkınma

44. Clinical and pathologic characteristics of patients with breast cancer and a second non-breast primary tumor.

Basaran G., Yazar A., Uras C., Tezcanli E. K., Cabuk D., Atalar B., et al.
49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 31 Mayıs - 04 Haziran 2013, cilt.31, (Özet Bildiri) Sürdürülebilir Kalkınma

45. Radyason Tedavisinde İnsan Hareketine Duyarlı Hasta ve Personel Güvenlik Sistemleri

LEVENT A., KEÇELİ A. S., AYDIN G., YAPICI B., ÖZYAR E.
13. Medikal Fizik Kongresi, İzmir, Türkiye, 17 - 19 Ekim 2011, (Özet Bildiri)

46. Serviks kanserli hastalarda F 18 FDG pozitron emisyon tomografisi tetkikinde primer tümörün ve lenf nodlarının FDG tutulum değerlerinin korelasyonu

UĞURLUER G., ATALAR B., SARAN İKİZLER H. A., SÖZER N., KİBAR M., SERİN M., et al.
XIX. Ulusal Kanser Kongresi, Türkiye, 20 - 24 Nisan 2011 Sürdürülebilir Kalkınma

47. The Evaluation of the Efficacy of Chemoradiotherapy(CRT) following Neo-adjuvant Treatment with Docetaxel(T)-Cisplatin(P) in Undifferentiated and Nonkeratinized Squamous Cell Carcinoma of the Nasopharynx - Phase IV Clinical Trial: A Turkish Oncology Group Study

Uzel O. E., ÖZYAR E., Pak Y., ABACIOGLU M. U., ALTUN M., KAPLAN B., et al.
51st Annual Meeting of the American-Society-for-Radiation-Oncology, Illinois, Amerika Birleşik Devletleri, 1 - 05 Kasım 2009, cilt.75, (Özet Bildiri)

48. Quantification of plasma epstein-barr virus DNA in patients with nasopharyngeal carcinoma: Preliminary results of a prospective study

Ozyar E., Gultekin M., Alp A., Hascelik G., Hosal S., Atahan I.
International Meeting on Innovative Approaches in Head and Neck Oncology, Barcelona, İspanya, 22 - 27 Şubat 2007, cilt.82, (Özet Bildiri)

49. Quantification of plasma Epstein-Barr virus DNA in patients with nasopharyngeal carcinoma: Preliminary results of a prospective study

Oezyar E., Gultekin M., Alp A., Gulsen G., Demir C., Atahan L.
Conference of the Spanish-Portuguese-and -Latin-American-Association, Leipzig, Almanya, 09 Ekim 2006, cilt.81, (Özet Bildiri)

50. Treatment results of 165 pediatric patients with non metastatic nasopharyngeal carcinoma a rare cancer network study (sözlü sunum)

Özyar E., Selek U., Laskar S., Uzel Ö. E., Anacak Y., Myriam B., et al.
Proc. ECCO 13-the European Cancer Conference, Paris, France, 30 October-3 November (Sözlü sunum), 2005, Paris, Fransa, 30 Ekim - 03 Kasım 2005, cilt.3, ss.354, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

51. Treatment results of 165 pediatric patients with non metastatic nasopharyngeal carcinoma A rare cancer network study (sözlü sunum)

Özyar E., Selek U., Laskar S., Uzel Ö. E., Anacak Y., Myriam B., et al.
Proc. 47th Annual Meeting of the American Society of Therapeutic Radiology, Denver, Colorado, 16-20 October, 2005, Colorado, Amerika Birleşik Devletleri, 16 - 20 Ekim 2005, cilt.63, ss.23, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

52. Radiotherapy in the treatment of mucosal melanoma of the upper aero-digestive tract. A rare cancer network study

Masini L., Krengli M., Kaanders J., Maingon P., Oei S., Zouhair A., et al.
23rd Annual Meeting of the European-Society-for-Therapeutic-Radiology-and-Oncology (ESTRO 23), Amsterdam, Hollanda, 24 - 28 Ekim 2004, cilt.73, (Özet Bildiri) Sürdürülebilir Kalkınma

53. Serum LDH level is a prognostic factor in locoregionally advanced nasopharyngeal carcinoma (NPC) patients treated with chemoradiotherapy

Turen S., Ozyar E., Altundag M., Gullu I.
3rd International Chicago Symposium on Malignancies of the Chest and Head and Neck, Illinois, Amerika Birleşik Devletleri, 7 - 09 Ekim 2004, cilt.46, (Özet Bildiri)

54. Assessment of quality life of nasopharyngeal carcinoma patients with EORTC QLQ C30 and H&N 30: Turkish oncology group, head and neck working party study

Cengiz M., ÖZYAR E., Esassolak M., Altun M., Akmansu M., ŞEN M., et al.
46th Annual Meeting of the American-Society-for-Therapeutic-Radiology-and-Oncology, Georgia, Amerika Birleşik Devletleri, 3 - 07 Ekim 2004, cilt.60, (Özet Bildiri)

55. Paranazal sinüs karsinomunda tedavi sonuçlarımız

ÇETİN B. E., GÜRKAYNAK H. M., ÖZYAR E., YILDIZ F., AKYOL H. F.
14. Ulusal Kanser Kongresi, İstanbul, Türkiye, 5 - 12 Mayıs 2001
Kitaplar 6

1. Pancreatic cancers

Uğurluer G., Güngör G., Özyar E.
MR Linac Radiotherapy: A new personalized treatment approach, Enis Ozyar,Cem Onal,Sara Hackett, Editör, Academic Press , Abohar, ss.315-334, 2022

2. Special consideration in pediatric nasopharyngeal cancer

Özyar E.
Nasopharyngeal cancer: A practical guide on diagnosis and treatment, jun Ma,Nancy Y. Lee,Jiade J. Lu, Editör, Springer, London/Berlin , Basel, ss.175-194, 2021

3. Radiation treatment for chordomas

Özyar E.
Chordomas, M.N. Pamir,O. Al-Mefty,L.A.B. Borba, Editör, Thieme (U.S) , Abohar, ss.187-192, 2017

4. Charged particle beams in management of clival chordomas

Özyar E.
Chordomas, M.N. Pamir,O. Al-Mefty,L.A.B. Borba, Editör, Thieme (U.S) , Abohar, ss.193-197, 2017

5. Nasopharyngeal cancer in pediatric and adolescent patients

Özyar E.
Nasopharyngeal Cancer Multidisciplinary Management, J.J.Lu,Jay.S. Cooper,Anne W.M. Lee, Editör, Springer, London/Berlin , Mannheim, ss.295-308, 2010 Sürdürülebilir Kalkınma

6. Uncommon tumors of the nasopharynx

Özyar E.
Management of Rare Adult Tumors, Y. Belkacemi,R.O. Mirimanoff,M. Ozsahin, Editör, Springer, London/Berlin , Agen, ss.87-96, 2010
Metrikler

Yayın

257

Yayın (WoS)

200

Yayın (Scopus)

159

Atıf (WoS)

2369

H-İndeks (WoS)

25

Atıf (Scopus)

2668

H-İndeks (Scopus)

28

Atıf (Scholar)

379

H-İndeks (Scholar)

10

Atıf (TrDizin)

2

H-İndeks (TrDizin)

1

Atıf (Sobiad)

2

H-İndeks (Sobiad)

1

Atıf (Diğer Toplam)

2

Proje

2

Tez Danışmanlığı

6

Açık Erişim

13
BM Sürdürülebilir Kalkınma Amaçları
SDG 3: AMAÇ 3: SAĞLIKLI BİREYLER
SDG 12: AMAÇ 12: SORUMLU ÜRETİM VE TÜKETİM
SDG 16: AMAÇ 16: BARIŞ VE ADALET